PVOTF

 
Ordinary Shares SEC Reporting - Current
OTCQB
Verified Company Profile 12/12/2016
Contact Info
  • 1275 West 6th Avenue
  • Vancouver, BC V6H 1A6
  • Canada

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Oct 31, 2016 10-Q
CIK 0001464165
Fiscal Year End 1/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: British Columbia, Canada
Year of Inc. 2002
Employees 3 a/o Feb 24, 2011
Company Officers/Contacts
Pravin Chaturvedi CEO
Moira Ong CFO, Principal Acct. Officer
Stewart Muglich Legal Counsel
Company Directors
Ahmad Doroudian Chairman
Pravin Chaturvedi
Patrick Frankham
Wolfgang Renz
Service Providers
Accounting/Auditing Firm
Sadler, Gibb & Associates, LLC
2455 E. Parleys Way
Suite 320
Salt Lake City, UT, 84109
United States
 
Securities Counsel
Alexander Holburn Beaudin + Lang LLP
2700-700 W Georgia Street
Vancouver, BC, V7Y 1B8
Canada
 
Investor Relations Firm
PCG Advisory Group
535 Fifth Avenue
24th Floor
New York, NY, 10017
United States
 
Company History
  • Formerly=Neurokine Pharmaceuticals Inc. until 4-2015
PVOTF Security Details
Share Structure
Market Value1 $9,455,888 a/o Mar 29, 2017
Authorized Shares Unlimited a/o Dec 01, 2016
Outstanding Shares 75,647,100 a/o Dec 09, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 48,431,680 a/o Dec 01, 2016
Par Value Not Available
Transfer Agent(s)
ClearTrust, LLC
Shareholders
Shareholders of Record 53 a/o Dec 01, 2016
Short Selling Data
Short Interest 597 (-96.02%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security